2004
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period
Formica RN, Friedman AL, Lorber MI, Bia MJ. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period. Transplantation Proceedings 2004, 36: 2675-2678. PMID: 15621121, DOI: 10.1016/j.transproceed.2004.10.013.Peer-Reviewed Original ResearchConceptsAngiotensin II receptor blockersEarly posttransplant periodII receptor blockersCalcium channel blockersTreatment of hypertensionPosttransplant periodReceptor blockersEnzyme inhibitorsAcute renal dysfunctionAdministration of ACEAdult renal transplantsAppropriate clinical criteriaRenal transplant patientsGlomerular filtration rateType of transplantUse of ACESerum potassium concentrationAllograft functionPancreas transplantsRenal dysfunctionRenal transplantTransplant patientsSerum creatininePosttransplant erythrocytosisSerum potassium
1982
The Effect of Dexamethasone on Renal Electrolyte Excretion in the Adrenalectomized Rat
BIA M, TYLER K, DEFRONZO R. The Effect of Dexamethasone on Renal Electrolyte Excretion in the Adrenalectomized Rat. Endocrinology 1982, 111: 882-888. PMID: 7106056, DOI: 10.1210/endo-111-3-882.Peer-Reviewed Original ResearchConceptsDose of dexamethasoneHigh dose of dexamethasoneRenal electrolyte excretionSodium excretionAdrenalectomized ratsK excretionElectrolyte excretionHigh dosesLow dosesLow dose of dexamethasoneLow dose of aldosteroneUrinary sodium excretionDose of aldosteroneDecreased sodium excretionLowest effective doseGlomerular filtration rateRenal potassium excretionUrinary K excretionAffecting sodium excretionK concentrationEffect of dexamethasoneAcute administrationUrinary potassiumPlasma K concentrationPotassium excretion